Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • In India OXXY launch hospital chain

    OXXY, with over 1 lakh medical centres already tied up under its belt, is all set to launch its hospital chain in India. OXXY, valued over USD 2 billion, is all set to launch hospitals in the metros and a few other cities under its belt in next few months. These hospitals will be from 50 bedded to 500 bedded capacity. No other model currently exists in India and its success will purely depend on the affordability of quality treatment and services directly in comparison with the global standards.

  • A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found. The vaccine partially protects the cynomolgus macaques against the EBOV-Makona strain if given three days prior, researchers said.

  • With over 75 per cent of people in India being unaware about the existence of Hepatitis, the leading gastroenterologists of the country have decided to start an online data registry detailing the rising number of hepatitis patients. "The need of setting up a registry was felt as over 75 per cent of the people in India do not even know that a disease like hepatitis exists," said a senior doctor at AIIMS. "The aim is to keep a record of the number of people suffering from hepatitis and other liver diseases caused by it in the country," the doctor said.

  • The researchers revealed that social factors such as a woman's education level and marital status before pregnancy can affect the birth weight of her daughters and granddaughters. The study findings tie social and biological factors together in determining causes for low birth weight. The study is published in the Journal of Health and Social Behavior.

  • A new study by researchers at Dana-Farber Cancer Center in Boston has revealed that drinking four or more cups of caffeinated coffee daily, or about 460 milligrams of caffeine, may significantly reduce the chances of recurrence of colon cancer in patients who were diagnosed with stage III of the disease. The study is published in the Journal of Clinical Oncology.

Subscribe to Pharma News